Biography:
Dr. Sergey Suchkov was born in Astrakhan, Russia, into a family of medical doctors. He earned his MD from Astrakhan State Medical University in 1980 and his PhD from Sechenov University in 1985. He received advanced training at the NIH (Bethesda, USA), Wills Eye Hospital (Philadelphia, USA), and several British universities under the Royal Society for Immunology. Dr. Suchkov has held numerous academic and leadership roles, including Director of the Division for Clinical Immunology & Immunobiotechnology at MONIKI, and Professor and Chair of the Department for Personalized & Precision Medicine at Sechenov University. He has also served as Vice-Director of the Institute for Biotech & Global Health at RosBioTech National University. Currently, Dr. Suchkov is Professor of Medicine & Immunology and Director of the Center for Biodesign at the N.D. Zelinskii Institute of Organic Chemistry, Russian Academy of Sciences. He also serves as R&D Director at InMedStar (Russia–UAE) and Senior Scientific Advisor to the China Hong Kong Innovation International Business Association. He is an active member of several international scientific organizations, including the New York Academy of Sciences, EPMA, ISPM, PMC, AMEE, ACS, AHA, ARVO, and ISER, and is Secretary General of the United Cultural Convention (UCC), Cambridge, UK.
Title : Antibody-proteases as translational tools of the next-step generation to be applied through biodesign-driven translational biotech in personalized and precision neurology practice
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Title : Antibody-Ppoteases as the upgraded translational tools of the next-step generation in personalized and precision practice to monitor multiple sclerosis at clinical and subclinical stages
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Title : Antibody-proteases as the upgraded translational tools of the next-step generation in personalized and precision neurology practice to monitor multiple sclerosis at clinical and subclinical stages
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up to secure the human healthcare, wellness and biosafety through the view of public health
Title : Antibody-proteases as translational tools of the next-step generation to be applied for clinical applications in personalized and precision neurology practice
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign, unique translational applications and upgraded business marketing to secure the human healthcare, wellness and biosafety
Title : Antibodies with functionality as a new generation of translational tools designed to monitor Multiple Sclerosis (MS) at clinical and subclinical stages